Adults and adolescents with herpes simplex infections, including recurrent cold sores or genital herpes, may be prescribed Zovirax tablets. Zovirax contains the antiviral aciclovir, which limits viral multiplication and can reduce the severity of an episode when treatment starts promptly. It does not remove herpes simplex virus from the body.
Zovirax tablets contain the antiviral aciclovir, which limits viral multiplication and can reduce the severity of an episode when treatment starts promptly. It is an oral antiviral treatment for infections caused by herpes simplex virus. These include herpes labialis, commonly called cold sores, and genital herpes; aciclovir is also used in treatment plans for shingles and chickenpox when clinically appropriate.
Zovirax tablets are taken by mouth with water. The amount, frequency, and length of treatment depend on the infection being treated and are agreed with a doctor or pharmacist. Courses for an initial genital herpes episode, recurrent cold sores, shingles, and prevention of repeated outbreaks are not interchangeable.
A practical routine includes:
Kidney function matters. Aciclovir leaves the body mainly through the kidneys, so prescribers may alter treatment plans for people with impaired renal function, dehydration, or medicines that affect kidney clearance.
Zovirax tablets contain the antiviral active substance aciclovir. Aciclovir limits the multiplication of herpes simplex virus and is used as an oral treatment for infections such as cold sores and genital herpes. The amount and duration of treatment depend on the infection and are agreed with a doctor or pharmacist.
Aciclovir is a nucleoside analogue antiviral. This means it resembles one of the building blocks used by viruses to make DNA, their genetic material. In cells infected with herpes simplex virus, a viral enzyme activates aciclovir more readily than it does in uninfected cells.
Zovirax reduces the virus’s ability to reproduce during treatment, while the immune system and individual recurrence pattern still shape the outcome.
Zovirax is an oral antiviral treatment for infections caused by herpes simplex virus. These include herpes labialis, commonly called cold sores, and genital herpes; aciclovir is also used in treatment plans for shingles and chickenpox when clinically appropriate.
Zovirax does not prevent every future recurrence. Its role is to treat an active episode or, for some people with frequent recurrences, to form part of a clinician-led suppression plan.
Several practical mistakes can reduce the benefit of antiviral treatment.
A second mistake is sharing a treatment plan with someone else who has similar symptoms. Herpes infections can look alike, yet the correct approach depends on whether this is a first episode, a recurrence, pregnancy status, immune status, kidney function, and the affected body area.
Extra caution is needed in the following situations:
Propylene glycol is relevant to some topical treatments, while tablet suitability depends on the ingredients in the prescribed oral formulation and the person’s allergy history. Tell the prescriber about every medicine you use, including lithium, methotrexate, immunosuppressants, and non-prescription anti-inflammatory medicines.
Zovirax is not for you if you have previously had an allergic reaction to aciclovir or valaciclovir. Valaciclovir is converted into aciclovir in the body, so a genuine allergy to one can matter for the other.
Most people tolerate oral aciclovir without major difficulty. Headache, nausea, diarrhoea, abdominal discomfort, dizziness, tiredness, or a skin rash can occur. These symptoms may also overlap with the viral illness itself, so timing and pattern matter.
Mild burning or stinging is more associated with topical aciclovir products than with tablets. With oral Zovirax, digestive symptoms and headache are more relevant practical concerns. Taking the tablet with water and keeping hydrated can help reduce avoidable discomfort.
Seek urgent medical assessment for signs of an allergic reaction, such as facial swelling, wheezing, widespread hives, blistering rash, or difficulty breathing. Confusion, hallucinations, marked drowsiness, tremor, reduced urine output, or severe flank pain also need urgent attention, especially in older adults or people with kidney disease. The EMA’s pharmacovigilance guidance supports prompt reporting and clinical review of suspected serious adverse reactions. [2]
Zovirax tablets contain aciclovir. Valaciclovir is closely related because the body converts it into aciclovir after absorption. Both are used against herpes simplex virus, while their dosing schedules and clinical use plans can differ.
| Treatment approach | Main feature | When it may be preferred |
|---|---|---|
| Aciclovir tablets | Direct antiviral active substance | Established option for treatment or suppression plans |
| Valaciclovir tablets | Converted to aciclovir after absorption | May suit some prescribed regimens with less frequent dosing |
| Topical aciclovir | Applied to a local cold sore | Limited local treatment for selected lip outbreaks |
Oral treatment may be preferred for genital herpes, more extensive outbreaks, recurrent episodes requiring a suppression plan, or situations where a local product would not address the affected area. A topical product can feel simpler for a small cold sore, yet it does not replace oral treatment where systemic therapy has been prescribed. NICE clinical guidance distinguishes oral herpes management from recurrent genital herpes plans according to symptoms, recurrence pattern, and individual risk factors. [1]
In clinical practice, doctors focus first on the diagnosis, the site of infection, the timing of symptoms, and kidney function. A recurrent cold sore in a healthy adult and a first episode of genital herpes do not call for the same treatment discussion. Eye pain, light sensitivity, a red eye, or a rash spreading over large areas changes the priority because herpes infection involving the eye requires urgent assessment.
Doctors also look at recurrence burden. Someone with rare, mild episodes may need treatment only when symptoms begin. Someone with frequent recurrences, severe symptoms, or a weakened immune system may need a more structured plan. Suppressive antiviral treatment can reduce outbreaks for selected patients, though it does not guarantee that transmission or recurrence will never occur.
The useful expectation is control, not eradication. Zovirax reduces the virus’s ability to reproduce during treatment, while the immune system and individual recurrence pattern still shape the outcome.
The MHRA’s 2024 aciclovir prescribing information advises individual assessment during pregnancy, weighing the treatment need against potential risk. Aciclovir has been used during pregnancy, and available human data have not identified a clear pattern of major birth defects, though treatment choices should remain personalised. Small amounts can pass into breast milk after oral use. A clinician should consider the infection being treated, the stage of pregnancy, renal function, and the baby’s age before deciding on treatment.
Zovirax does not usually require tapering because aciclovir does not cause physical dependence. The MHRA's 2024 prescribing information describes aciclovir as an antiviral that acts while it is present at therapeutic levels; stopping ends that antiviral pressure. For a short treatment course, the usual goal is to complete the prescribed duration. For long-term suppression, a clinician may review whether continued treatment remains useful, since recurrences can return after stopping.
Older adults can use aciclovir when it is clinically suitable, though renal function deserves closer attention. The WHO's 2024 information recognises that herpes simplex infections occur across adulthood, while age-related changes in kidney clearance can alter how medicines are handled. Lower kidney function can raise aciclovir exposure and increase the chance of neurological adverse effects such as confusion or agitation. Prescribers may adjust the regimen and review other medicines that place strain on the kidneys.
The best time depends on the dosing plan prescribed for the infection. When Zovirax is taken more than once daily, evenly spaced doses help maintain antiviral activity rather than clustering tablets around meals or bedtime. The MHRA's 2024 prescribing information supports dose adjustment based on indication and renal function, so there is no single best clock time for every person. Linking doses to established daily routines can make adherence easier.
Take the missed tablet when remembered unless it is nearly time for the next scheduled dose. If the next dose is due soon, skip the forgotten tablet and continue the regular schedule. Do not take two doses together, because doubling does not restore the missed interval and can increase unwanted effects. This approach aligns with the MHRA's 2024 medicine-safety advice for oral antiviral dosing.
Discuss previous reactions to aciclovir or valaciclovir, kidney disease, low fluid intake, pregnancy or breastfeeding, and all medicines or supplements you use. Mention immunosuppressants, probenecid, cimetidine, lithium, methotrexate, ciclosporin, tacrolimus, and frequent use of anti-inflammatory pain medicines. NICE guidance published in 2024 also supports clinical assessment for severe, frequent, atypical, or recurrent herpes symptoms. Eye symptoms, widespread lesions, or reduced immunity require prompt medical attention.
Aciclovir is absorbed after an oral dose and is cleared mainly through the kidneys, which is why treatment plans often use repeated doses rather than a single tablet for an entire day. The precise duration of antiviral activity varies with the prescribed regimen, kidney function, hydration, and the infection being treated. The EMA's 2017 guidance explains that medicine safety monitoring considers factors such as dose exposure, organ function, and adverse-effect patterns. Follow the agreed dosing schedule rather than judging coverage by symptom changes alone.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
I began the tablets when the familiar tingling started rather than waiting for the blister. The outbreak still appeared, but it stayed smaller than my usual ones and settled without cracking as much.
The first few days were uncomfortable and I was anxious about what to expect. Taking the tablets at set times made the routine easier, and the soreness gradually eased during the prescribed course.
I had a mild headache on the first day and made sure I drank more water. It passed, and I found starting treatment early made more difference than I expected.
The tablets were manageable, but the number of daily reminders was annoying while I was at work. I missed one dose, took the next scheduled one, and carried on without trying to catch up.
My doctor reviewed my kidney medicines before starting Zovirax, which reassured me. The treatment helped, although I needed to keep a written schedule because the timing was easy to lose track of.
